Overexpression of Interleukin-1β Induces Gastric Inflammation and Cancer and Mobilizes Myeloid-Derived Suppressor Cells in Mice

被引:818
作者
Tu, Shuiping [1 ]
Bhagat, Govind [2 ]
Cui, Guanglin
Takaishi, Shigeo [1 ]
Kurt-Jones, Evelyn A. [3 ,6 ]
Rickman, Barry [4 ]
Betz, Kelly S. [1 ]
Penz-Oesterreicher, Melitta [1 ]
Bjorkdahl, Olle [5 ]
Fox, James G. [4 ]
Wang, Timothy C. [1 ]
机构
[1] Columbia Univ, Coll Phys & Surg, Dept Med, New York, NY 10032 USA
[2] Columbia Univ, Coll Phys & Surg, Dept Pathol, New York, NY 10032 USA
[3] Univ Tromso, Inst Clin Med, Lab Gastroenterol, N-9037 Tromso, Norway
[4] MIT, Div Comparat Med, Cambridge, MA 02139 USA
[5] Pharmexa AS, DK-2970 Horsholm, Denmark
[6] Univ Massachusetts, Dept Med, Sch Med, Worcester, MA 01655 USA
基金
美国国家卫生研究院;
关键词
D O I
10.1016/j.ccr.2008.10.011
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Polymorphisms of interleukin-1 beta (IL-1 beta) are associated with an increased risk of solid malignancies. Here, we show that stomach-specific expression of human IL-1 beta in transgenic mice leads to spontaneous gastric inflammation and cancer that correlate with early recruitment of myeloid-derived suppressor cells (MDSCs) to the stomach. IL-1 beta activates MDSCs in vitro and in vivo through an IL-1Rl/NF-kappa B pathway. IL-1 beta transgenic mice deficient in T and B lymphocytes develop gastric dysplasia accompanied by a marked increase in MDSCs in the stomach. Antagonism of IL-1 receptor signaling inhibits the development of gastric preneoplasia and suppresses MDSC mobilization. These results demonstrate that pathologic elevation of a single proinflammatory cytokine may be sufficient to induce neoplasia and provide a direct link between IL-1 beta MDSCs, and carcinogenesis.
引用
收藏
页码:408 / 419
页数:12
相关论文
共 44 条
[1]
Matrix metalloproteinase-9 is required for tumor vasculogenesis but not for angiogenesis: Role of bone marrow-derived myelomonocytic cells [J].
Ahn, G-One ;
Brown, J. Martin .
CANCER CELL, 2008, 13 (03) :193-205
[2]
Increased production of immature myeloid cells in cancer patients: A mechanism of immunosuppression in cancer [J].
Almand, B ;
Clark, JI ;
Nikitina, E ;
van Beynen, J ;
English, NR ;
Knight, SC ;
Carbone, DP ;
Gabrilovich, DI .
JOURNAL OF IMMUNOLOGY, 2001, 166 (01) :678-689
[3]
The balance between IL-1 and IL-1Ra in disease [J].
Arend, WR .
CYTOKINE & GROWTH FACTOR REVIEWS, 2002, 13 (4-5) :323-340
[4]
TNF-α in promotion and progression of cancer [J].
Balkwill, Frances .
CANCER AND METASTASIS REVIEWS, 2006, 25 (03) :409-416
[5]
A polymorphism of the interleukin-1β gene influences survival in pancreatic cancer [J].
Barber, MD ;
Powell, JJ ;
Lynch, SF ;
Fearon, KCH ;
Ross, JA .
BRITISH JOURNAL OF CANCER, 2000, 83 (11) :1443-1447
[6]
Nonsteroidal anti-inflammatory drugs and cancer prevention [J].
Baron, JA ;
Sandler, RS .
ANNUAL REVIEW OF MEDICINE, 2000, 51 :511-523
[7]
Cytokine gene polymorphism in human disease: on-line databases [J].
Bidwell, J ;
Keen, L ;
Gallagher, G ;
Kimberly, R ;
Huizinga, T ;
McDermott, MF ;
Oksenberg, J ;
McNicholl, J ;
Pociot, F ;
Hardt, C ;
D'Alfonso, S .
GENES AND IMMUNITY, 1999, 1 (01) :3-19
[8]
Björkdahl O, 1999, IMMUNOLOGY, V96, P128
[9]
Inflammation induces myeloid-derived suppressor cells that facilitate tumor progression [J].
Bunt, SK ;
Sinha, P ;
Clements, VK ;
Leips, J ;
Ostrand-Rosenberg, S .
JOURNAL OF IMMUNOLOGY, 2006, 176 (01) :284-290
[10]
Reduced inflammation in the tumor microenvironment delays the accumulation of myeloid-derived suppressor cells and limits tumor progression [J].
Bunt, Stephanie K. ;
Yang, Linglin ;
Sinha, Pratima ;
Clements, Virginia K. ;
Leips, Jeff ;
Ostrand-Rosenberg, Suzanne .
CANCER RESEARCH, 2007, 67 (20) :10019-10026